Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Scientific, Medinol Coronary Stent IDE Approvals Precede Legal Duel

Mar 25 2002

Related Content

Boston Scientific Paclitaxel Stent Restenosis Rate Is Zero At Six Months

Oct 01 2001

Boston Scientific Express Stent Potentially Threatened By Medinol Lawsuit

Apr 09 2001

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window